David W. Rowe

18.4k total citations · 3 hit papers
222 papers, 13.5k citations indexed

About

David W. Rowe is a scholar working on Molecular Biology, Genetics and Rheumatology. According to data from OpenAlex, David W. Rowe has authored 222 papers receiving a total of 13.5k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Molecular Biology, 58 papers in Genetics and 45 papers in Rheumatology. Recurrent topics in David W. Rowe's work include Connective tissue disorders research (34 papers), Bone and Dental Protein Studies (29 papers) and Bone Metabolism and Diseases (26 papers). David W. Rowe is often cited by papers focused on Connective tissue disorders research (34 papers), Bone and Dental Protein Studies (29 papers) and Bone Metabolism and Diseases (26 papers). David W. Rowe collaborates with scholars based in United States, United Kingdom and Japan. David W. Rowe's co-authors include Barbara E. Kream, Ivo Kalajzić, Alexander C. Lichtler, Žana Kalajzić, Xi Jiang, Héctor L. Aguila, Peter Maye, Dora Višnjić, Nathaniel A. Dyment and Mark S. Kronenberg and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

David W. Rowe

219 papers receiving 13.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche

2008 676 citations Cristina Lo Celso, Heather E. Fleming et al. Nature profile →
Hematopoiesis is severely altered in mice with an induced osteoblast deficiency

2004 566 citations David W. Rowe, Héctor L. Aguila et al. profile →
Construction of DNA sequences complementary to rat .alpha.1 and .alpha.2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D

1984 556 citations David W. Rowe et al. profile →

Peers

Countries citing papers authored by David W. Rowe

Since Specialization

Citations

This map shows the geographic impact of David W. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Rowe more than expected).

Fields of papers citing papers by David W. Rowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Rowe. The network helps show where David W. Rowe may publish in the future.

Co-authorship network of co-authors of David W. Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Rowe. A scholar is included among the top collaborators of David W. Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Rowe. David W. Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic Deficiency of Hyaluronan Synthase 2 in the Developing Limb Mesenchyme Impairs Postnatal Synovial Joint Formation 2025 ·Biomedicines ·Yingcui Li, (unknown), Peter Maye, Kirsten M. Edwards, (unknown), Nathaniel A. Dyment, Yu Yamaguchi, David W. Rowe, (unknown), Sunny Sun-Kin Chan, Kevin W.‐H. Lo	0
2	Senolytics improve bone forming potential of bone marrow mesenchymal stem cells from aged mice 2021 ·npj Regenerative Medicine ·Yueying Zhou, Xiaonan Xin, Lichao Wang, Binsheng Wang, Li Chen, Ousheng Liu, David W. Rowe, Ming Xu	68
3	Parental Origin of Gsα Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy 2021 ·JBMR Plus ·(unknown), Peter Maye, (unknown), David W. Rowe, Emily L. Germain‐Lee	6
4	Effects of acidosis on the structure, composition, and function of adult murine femurs 2020 ·Acta Biomaterialia ·(unknown), (unknown), (unknown), Ron Ben Abraham, Tannin A. Schmidt, David W. Rowe, Alix Deymier	13
5	Transplanting cells from old but not young donors causes physical dysfunction in older recipients 2020 ·Aging Cell ·Binsheng Wang, (unknown), (unknown), Lichao Wang, Christina L. Inman, Yueying Zhou, Chun Guo, Tamar Tchkonia, David W. Rowe, George A. Kuchel, Paul Robson, James L. Kirkland, Ming Xu	53
6	Intrafibrillar Mineralized Collagen–Hydroxyapatite-Based Scaffolds for Bone Regeneration 2020 ·ACS Applied Materials & Interfaces ·Le Yu, David W. Rowe, (unknown), Jiyao Zhang, Steven L. Suib, Xiaonan Xin, Mei Wei	114
7	Osteochondral Differentiation of Fluorescent Multireporter Cells on Zonally-Organized Biomaterials 2018 ·Tissue Engineering Part A ·(unknown), Xiaonan Xin, Sumit Yadav, David W. Rowe, Mei Wei	5
8	Improved biomechanical and biological outcomes in the MRL/MpJ murine strain following a full‐length patellar tendon injury 2015 ·Journal of Orthopaedic Research® ·Andrea L. Lalley, Nathaniel A. Dyment, Namdar Kazemi, Keith Kenter, Cynthia Gooch, David W. Rowe, David L. Butler, Jason T. Shearn	20
9	Combination therapy with PTH and DBM cannot heal a critical sized murine femoral defect 2015 ·Journal of Orthopaedic Research® ·Michael Pensak, (unknown), Alex G. Dukas, (unknown), (unknown), (unknown), Amy Tang, David W. Rowe, Jay R. Lieberman	7
10	Fibrin Gels Exhibit Improved Biological, Structural, and Mechanical Properties Compared with Collagen Gels in Cell-Based Tendon Tissue-Engineered Constructs 2014 ·Tissue Engineering Part A ·Andrew P. Breidenbach, Nathaniel A. Dyment, Yinhui Lu, Marepalli B. Rao, Jason T. Shearn, David W. Rowe, Karl E. Kadler, David L. Butler	45
11	Roles of Parathyroid Hormone (PTH) Receptor and Reactive Oxygen Species in Hyperlipidemia‐Induced PTH Resistance in Preosteoblasts 2013 ·Journal of Cellular Biochemistry ·Xin Li, Jamie N. Garcia, Jinxiu Lu, (unknown), Ivo Kalajzić, David W. Rowe, Linda L. Demer, Yin Tintut	10
12	Developmental-Like Bone Regeneration by Human Embryonic Stem Cell-Derived Mesenchymal Cells 2013 ·Tissue Engineering Part A ·Liisa T. Kuhn, Yongxing Liu, Nolan L. Boyd, James E. Dennis, Xi Jiang, Xiaonan Xin, Lyndon F. Charles, Liping Wang, Héctor L. Aguila, David W. Rowe, Alexander C. Lichtler, A. Goldberg	45
13	Visualizing Osteogenesis In Vivo Within a Cell–Scaffold Construct for Bone Tissue Engineering Using Two-Photon Microscopy 2013 ·Tissue Engineering Part C Methods ·Max M. Villa, Liping Wang, Jianping Huang, David W. Rowe, Mei Wei	29
14	The Paratenon Contributes to Scleraxis-Expressing Cells during Patellar Tendon Healing 2013 ·PLoS ONE ·Nathaniel A. Dyment, Chia‐Feng Liu, Namdar Kazemi, Lindsey Aschbacher‐Smith, Keith Kenter, Andrew P. Breidenbach, Jason T. Shearn, Christopher Wylie, David W. Rowe, David L. Butler	115
15	Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo 2012 ·The Journal of Experimental Medicine ·(unknown), Mathieu-Benoı̂t Voisin, Abigail Woodfin, James R. Whiteford, Fulvio D’Acquisto, Gareth E. Jones, David W. Rowe, Sussan Nourshargh	371
16	ABL1 fusion genes in hematological malignancies: a review 2011 ·European Journal Of Haematology ·Étienne De Braekeleer, Nathalie Douet‐Guilbert, David W. Rowe, Nick Bown, Fréderic Morel, Christian Berthou, Claude Férec, Marc De Braekeleer	66
17	Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche breakdown → 2008 ·Nature ·Cristina Lo Celso, Heather E. Fleming, Juwell W. Wu, Cher X. Zhao, (unknown), Joji Fujisaki, Daniel Côté, David W. Rowe, Charles P. Lin, David T. Scadden	676
18	Inhibiting expression of specific genes in mammalian cells with 5′ end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA 2003 ·Proceedings of the National Academy of Sciences ·Puri Fortes, Yolanda Cuevas, Fei Guan, Peng Liu, (unknown), (unknown), Maria Luz Martínez‐Chantar, Jesús Prìeto, David W. Rowe, Samuel Gunderson	69
19	Osteoblastic Response to the Defective Matrix in the Osteogenesis Imperfecta Murine (oim) Mouse 2002 ·Endocrinology ·Ivo Kalajzić, Janoš Terzić, Zvonko Rumboldt, (unknown), (unknown), Felicia Ledgard, Gloria Gronowicz, Stephen H. Clark, David W. Rowe	41
20	Patients with Ehlers-Danlos syndrome type IV lack type III collagen. 1975 ·Proceedings of the National Academy of Sciences ·F M Pope, George R. Martin, J R Lichtenstein, Risto Penttinen, (unknown), David W. Rowe, V.A. McKusick	336

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact